A number of AI patents have been embedded in medical diagnostic products. 30% of the company's R & D staff specialize in AI, and domestic sales are expected to double for the whole year; another "small and beautiful" has greatly improved its profitability in the first quarter, with "national company."

A number of AI patents of ① have been embedded in medical diagnostic products. 30% of the company's R & D personnel specialize in AI, and the product landing is expected to quickly fill the physician gap. Analysts expect domestic sales to double in 2023 and the apparent growth rate of export sales by 60%. ② hundreds of billions of market space to open up, this consumer "small but beautiful" profitability increased significantly in the first quarter, and has the long-term focus of "national chain + city integration".